There was also a strong dose-dependent association between increasing IGF-I plasma levels and PCa risk (odds ratio, OR = 3.92; 95% confidence interval, CI = 1.58 - 9.70), when IGF-I levels were higher than 151.7 ng/ml. The gene discussed is IGF1; the disease is posterior cortical atrophy.